Downstream Processing Featured Articles

61. Additional Details Concerning Issue Of Shares To Johnson & Johnson Development Corporation As Part Of The Daratumumab Agreement 8/30/2012

    Genmab A/S announced recently additional details concerning the subscription of shares by Johnson & Johnson Development Corporation (JJDC) as part of the global license and development agreement for daratumumab (HuMax-CD38) between Genmab (see Genmab's Company Announcement 20) and Janssen Biotech, Inc., one of the Janssen Pharmaceutical companies of Johnson & Johnson.

62. NIH-Supported Study Shows How Immune Cells Change Wiring Of The Developing Mouse Brain 5/23/2012

    Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development. 

63. Lonza And OncoMed Pharmaceuticals Sign A Process Development And Manufacturing Collaboration And Multi-Product GS License Agreement For Anti-Cancer Therapeutics 10/23/2012

    Lonza, a global leader in biological manufacturing and OncoMed Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced recently an agreement for the development and manufacture of OncoMed’s pipeline of anti-cancer stem cell therapeutics.

64. Closer Look At Cell Membrane Shows Cholesterol 'Keeping Order' 11/12/2012

    Cell membranes form the “skin” of most every cell in your body, but the ability to view them up close and in motion cannot be rendered by many experimental techniques. A team of scientists working at the National Institute of Standards and Technology (NIST) and University of California, Irvine, recently developed a way to magnify them dramatically.

65. FlexFill Single-Use Transfer Assembly 10/3/2011
    Meissner introduces its new FlexFill single-use biocontainer transfer assembly. The assembly is ideally suited for applications requiring fast and dependable aseptic transfer of small liquid process volumes.
66. Thallion And LFB Terminate Shigamabs Collaboration 2/20/2013

    Thallion Pharmaceuticals Inc. (TSX-V: TLN) ("Thallion") and LFB Biotechnologies ("LFB") today announced that they have reached an agreement on the termination of their Development and Licensing Agreement related to Thallion's Shigamabs® program.

67. New' Estrogen Receptor Found To Be Key Player In Tamoxifen Resistance 10/31/2008
    Researchers at Georgetown University Medical Center have discovered a novel way in which breast cancer cells become resistant to tamoxifen, the world's largest-selling breast cancer prevention and treatment drug.
68. Vaccine And Antibiotics Stabilized So Refrigeration Is Not Needed 7/10/2012

    Researchers funded by the National Institutes of Health have developed a new silk-based stabilizer that, in the laboratory, kept some vaccines and antibiotics stable up to temperatures of 140 degrees Fahrenheit. This provides a new avenue toward eliminating the need to keep some vaccines and antibiotics refrigerated, which could save billions of dollars every year and increase accessibility to third world populations.

69. New Biofuel Process Dramatically Improves Energy Recovery 7/10/2012

    A new biofuel production process created by Michigan State University researchers produces 20 times more energy than existing methods.

70. Endress+Hauser Introduces OUSBT66 Cell Density Sensor 4/1/2013

    Endress+Hauser introduces the OUSBT66 sensor for cell density measurement. Using near-Infrared (NIR) light absorbance technology, the OUSBT66 is a non-intrusive, hygienic sensor that is ideal for real time, in-situ cell production optimization in life science processes, fermentation biomass measurement and algae growth monitoring for biofuel production.